NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein

European Journal of Immunology - United Kingdom
doi 10.1002/eji.201847550
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Delivery of NKG2D Ligand Using an Anti-Her2 Antibody-Nkg2d Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response

Cancer Research
Cancer ResearchOncology
2010English

Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions

Journal of Immunology
AllergyImmunology
2012English

The HCMV Protein UL148A Downregulates the Activating NK Cell Ligand MICA to Avoid NK Cell Attack

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Defucosylated Chimeric Anti-Cc Chemokine Receptor 4 IgG1 With Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma

Cancer Research
Cancer ResearchOncology
2004English

VEGFR2 Targeted Antibody Fused With MICA Stimulates NKG2D Mediated Immunosurveillance and Exhibits Potent Anti-Tumor Activity Against Breast Cancer

Oncotarget
Oncology
2016English

Radioimmunotherapy for Model B Cell Malignancies Using 90y-Labeled Anti-Cd19 and Anti-Cd20 Monoclonal Antibodies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2008English

The Mechanism of Anti-CD20–mediated B Cell Depletion Revealed by Intravital Imaging

Journal of Clinical Investigation
Medicine
2013English

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy